Strategic Positioning Identify and approach i3 Research as a proponent of integrated lifecycle solutions in pharmaceutical manufacturing, emphasizing its status as a global services provider connected to Ingenix and UnitedHealth Group to open doors for enterprise partnerships and extended service scopes.

Financial Footprint Leverage i3's scale and revenue potential by tailoring enterprise-grade solutions, noting the company operates within a multi-billion dollar affiliate network and is actively engaging in investor activities, signaling readiness for larger programs and long-term contracts.

Tech Enablement Highlight opportunities around leveraging i3’s technology stack and data capabilities to enhance product lifecycle management, regulatory submissions, and operational analytics, aligning offerings with their emphasis on knowledge and information services.

Expansion Readiness Position offerings that support global clinical development, manufacturing, and supply chain scalability, particularly services that can scale with i3’s growth through corporate ties and potential multinational deployments.

Sustainability & Compliance Propose solutions focused on compliance efficiency, quality assurance, and sustainable manufacturing practices that align with a major healthcare services ecosystem, appealing to i3’s integration of health information services and lifecycle strategy.